Suyog M. Amrutkar - Concepedia

Author

Suyog M. Amrutkar

National Institute of Pharmaceutical Education and Research ORCID

Also Known As

Amrutkar, Suyog, Suyog Amrutkar, Suyog M. Amrutkar, Suyog Madhav Amrutkar

Publications

358

Citations

H-Index

Concepts

All Affiliations

National Institute of Pharmaceutical Education and Research Central University of Punjab KIIT University Centre For Human Genetics University of Central Punjab

About

Suyog M. Amrutkar is an author at National Institute of Pharmaceutical Education and Research specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	256
2	Biochemistry	6	6	226
3	Natural Sciences	4	4	180
4	Biomolecular Engineering	3	3	57
5	Engineering	1	1	10

Suyog M. Amrutkar

Publications

358

Citations

H-Index

Page 1

	Year	Citations
Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors Ashish T. Baviskar, Suyog M. Amrutkar, Neha Trivedi, ACS Medicinal Chemistry Letters Drug TargetKnown LigandsChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2015	87
Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα Garima Priyadarshani, Suyog M. Amrutkar, Anmada Nayak, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryTopoisomerase IiαBioactive FlavonoidsPotent Anticancer Agents	2016	49
Imine/amide–imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-α inhibition Arvind Negi, Jimi Marin Alex, Suyog M. Amrutkar, Bioorganic & Medicinal Chemistry	2015	44
Scaffold-Hopping of Aurones: 2-Arylideneimidazo[1,2-<i>a</i>]pyridinones as Topoisomerase IIα-Inhibiting Anticancer Agents Garima Priyadarshani, Anmada Nayak, Suyog M. Amrutkar, ACS Medicinal Chemistry Letters	2016	41
E-pharmacophore guided discovery of pyrazolo[1,5-c]quinazolines as dual inhibitors of topoisomerase-I and histone deacetylase Gaurav Joshi, Sourav Kalra, Umesh Prasad Yadav, Bioorganic Chemistry BiochemistryDual InhibitorsMedicineRational Drug DesignPharmacotherapy	2019	36
Dual inhibitors of epidermal growth factor receptor and topoisomerase IIα derived from a quinoline scaffold Monika Chauhan, Gaurav Joshi, Harveen Kler, RSC Advances Pharmaceutical ScienceEgfr Kinase InhibitoryPharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	2016	30
Synthesis and biological evaluation of new 2,5-dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors Darpan Darpan, Gaurav Joshi, Suyog M. Amrutkar, RSC Advances Pharmaceutical ScienceBioorganic ChemistryN-acetyl PyrazolinesOrganic ChemistryPharmacotherapy	2016	29
One-pot synthesis of (R)-1-(1-naphthyl)ethanol by stereoinversion using Candida parapsilosis Suyog M. Amrutkar, Linga Banoth, Uttam Chand Banerjee Tetrahedron Letters Natural Product SynthesisAntifungal AgentBiomolecular EngineeringCandida Parapsilosis	2013	17
Anticancer activity of dihydropyrazolo[1,5‐<i>c</i>]quinazolines against rat C6 glioma cells via inhibition of topoisomerase II Gagandeep Kaur, Ravi P. Cholia, Gaurav Joshi, Archiv der Pharmazie Medicinal ChemistryChemoprevention StrategyGliomaBiochemistryTopoisomerase Ii	2018	15
Sulfinate Based Selective Labeling of 5-Hydroxymethylcytosine: Application to Biotin Pull Down Assay Qiong Wu, Suyog M. Amrutkar, Fangwei Shao Bioconjugate Chemistry EngineeringEpigenetic ChangeDna MethylationDna AnalysisMolecular Biology	2018	10

Page 1